Go J Yoshida

Researcher Name Resolver ID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 16

Top Venues

Journal of occupational health

Journal of experimental & clinical cancer research : CR

Proceedings of the National Academy of Sciences of the United States of America

Apoptosis : an international journal on programmed cell death

Juntendo University School of Medicine

Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Juntendo University School of Medicine Dec 01 2018

Japan

Assistant Professor :: Department of Pathology and Oncology

Education History

Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka Apr 01 2011 - Mar 20 2014

Japan

PHD :: Gene Regulation Department

Keio University School of Medicine Apr 01 2004 - Mar 31 2010

Japan

PHD

Publications

Go J Yoshida
The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells. Metabolites 11 (1) (2021)
Christos C Zouboulis, Go J Yoshida, Yaojiong Wu, Longqing Xia, Marlon R Schneider
Sebaceous gland: Milestones of 30-year modelling research dedicated to the "brain of the skin". Experimental dermatology 29 (11) (2020)
Go J Yoshida
The therapeutic strategy of drug re-positioning to induce autophagic cell death in brain malignancy. Apoptosis : an international journal on programmed cell death 25 (7-8) (2020)
Go J Yoshida
The interplay between apoptosis and ferroptosis mediated by ER stress. Apoptosis : an international journal on programmed cell death 25 (11-12) (2020)
Go J Yoshida
Applications of patient-derived tumor xenograft models and tumor organoids. Journal of hematology & oncology 13 (1) (2020)
Go J Yoshida
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. Journal of experimental & clinical cancer research : CR 39 (1) (2020)
Go J Yoshida
Comment on "Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients". Molecular diagnosis & therapy 22 (4) (2019)
Go J Yoshida
Beyond Stanton and Pott hypothesis; carbon nanotubes-induced malignant mesothelioma as a disease of gene loss. Journal of occupational health 61 (2) (2019)
Go J Yoshida
Emergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise. Journal of occupational health 61 (2) (2019)
Victor C Kok, Yu-Ching Chen, Yang-Yuan Chen, Yu-Chieh Su, Ming-Chang Ku, Jung-Tsung Kuo, Go J Yoshida
Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study. Cancers 11 (7) (2019)
Go J Yoshida
Molecular machinery underlying the autophagic regulation by MDA-9/Syntenin leading to anoikis resistance of tumor cells. Proceedings of the National Academy of Sciences of the United States of America 115 (33) (2018)
Go J Yoshida
[The emerging role of artificial intelligence in clinical and basic medicine]. Sangyo eiseigaku zasshi = Journal of occupational health 60 (5) (2018)
Go J Yoshida
Emerging roles of Myc in stem cell biology and novel tumor therapies. Journal of experimental & clinical cancer research : CR 37 (1) (2018)
Go J Yoshida
How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence? Proceedings of the National Academy of Sciences of the United States of America 115 (28) (2018)
Go J Yoshida
Legionnaires' disease as an occupational risk related to decontamination work after the Fukushima nuclear disaster: A case report. Journal of occupational health 60 (6) (2018)
Go J Yoshida
Regarding "Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms". The oncologist 23 (10) (2018)

Go J Yoshida.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Go J Yoshida